$4.22
-0.07-1.63%
al cierre: Nov 21, 4:00 PM EST
$4.16
-0.0593-1.41%
After hour: 6:14 PM EST
Comments
Loading...
Agenus Actividad de operaciones con información privilegiada
AGENNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de Agenus. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de Agenus.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo Agenus Inc los iniciados?
Los expertos no han informado de compras ni ventas en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
Estadísticas de propiedad de Agenus Inc
Acciones en circulación
34.008M
Acciones en manos de personas con información privilegiada
7.022M
Porcentaje de acciones en manos de personas con información privilegiada
22.0%
Acciones en manos de instituciones
3.608M
Porcentaje de acciones en manos de instituciones
11.0%
Feb 15, 2024 | SEE REMARKS | 500.00K | $0.65 | $324.05K | BUY | 70.93% | 1.20M | Feb 15 | ||
Nov 17, 2023 | — | 25.00K | $0.76 | $19.00K | BUY | 25.24% | 124.06K | Nov 15 | ||
Jan 06, 2022 | CHIEF MEDICAL OFFICER | 61.32K | $3.06 | -$118.35K | SELL-OPTIONS | ∞ | 61.32K | Jan 04 - Jan 06 | ||
Sep 14, 2021 | CHAIRMAN AND CEO | 37.07K | $4.93 | -$133.26K | SELL-OPTIONS | 2.82% | 1.35M | Sep 13 | ||
Sep 14, 2021 | PFO & PAO | 5.44K | $4.93 | -$16.63K | SELL-OPTIONS | 6.21% | 93.06K | Sep 10 | ||
Jun 18, 2020 | — | -214.00K | $3.66 | -$782.84K | SELL | -1.25% | 16.97M | Jun 16 - Jun 17 | ||
Jun 15, 2020 | — | -577.00K | $3.64 | -$2.10M | SELL | -3.25% | 17.19M | Jun 11 - Jun 15 | ||
Dec 14, 2017 | CHIEF COMMERCIAL OFFICER | 9.37K | $3.53 | $34.11K | GRANT | 18.96% | 58.79K | Oct 09 - Dec 12 | ||
Dec 14, 2017 | CHIEF COMMUNICATIONS OFFICER | 6.92K | $3.53 | $25.30K | GRANT | 24.08% | 35.66K | Oct 09 - Dec 12 | ||
Dec 14, 2017 | CHIEF TECHNOLOGY OFFICER | 6.88K | $3.53 | $25.54K | GRANT | 48.60% | 21.03K | Oct 09 - Dec 12 | ||
Dec 14, 2017 | VP, FINANCE | 4.82K | $3.53 | $18.03K | GRANT | 8.10% | 64.33K | Oct 09 - Dec 12 | ||
Dec 14, 2017 | CHIEF LEGAL OFFICER | 16.47K | $3.53 | $60.20K | GRANT | 19.36% | 101.52K | Oct 09 - Dec 12 | ||
Apr 12, 2017 | CHAIRMAN & CEO | 100.00K | $3.35 | $334.52K | BUY | 7.56% | 1.42M | Apr 10 - Apr 12 | ||
Feb 14, 2017 | 10% OWNER | 10.00M | $6.00 | $60.00M | BUY | 128.80% | 17.76M | Feb 14 | ||
Sep 08, 2016 | DIRECTOR | 30.00K | $6.29 | $188.70K | BUY | ∞ | 30.00K | Sep 06 | ||
May 10, 2016 | CHAIRMAN & CEO | 100.00K | $3.18 | $317.89K | BUY | 7.72% | 1.40M | May 05 - May 09 | ||
May 09, 2016 | CHIEF BUSINESS OFFICER | 2.25K | $3.10 | $6.97K | BUY | 7.19% | 33.54K | May 05 | ||
Mar 08, 2016 | CHAIRMAN & CEO | 200.00K | $4.03 | $805.60K | BUY | 19.03% | 1.25M | Mar 07 | ||
Dec 30, 2015 | CHAIRMAN & CEO | -381.58K | $4.61 | -$1.76M | SELL | -23.08% | 1.27M | Dec 28 - Dec 30 | ||
Sep 29, 2015 | CHAIRMAN & CEO | 100.00K | $5.03 | $503.00K | BUY | 6.20% | 1.71M | Sep 25 | ||
Sep 29, 2015 | CHIEF FINANCIAL OFFICER | 10.00K | $5.05 | $50.50K | BUY | ∞ | 10.00K | Sep 25 | ||
Apr 30, 2015 | DIRECTOR | -996.09K | $5.05 | -$7.54M | SELL | -100.00% | 0.00 | May 08 - Apr 29 | ||
Jan 13, 2015 | 10% OWNER | -2.34M | $5.31 | -$12.45M | SELL | -25.31% | 6.92M | Jan 09 | ||
Feb 28, 2014 | VP, CLINICAL, REG & QUAL | -5.00K | $5.00 | -$25.00K | SELL | -8.01% | 57.41K | Feb 26 | ||
Jan 24, 2014 | VP GENERAL COUNSEL | -2.85K | $3.50 | -$9.97K | SELL | -5.24% | 51.53K | Jan 23 | ||
Feb 01, 2013 | DIRECTOR | -288.00 | $4.36 | -$1.26K | SELL | -0.35% | 81.31K | Jan 30 | ||
Nov 01, 2012 | DIRECTOR | -288.00 | $4.40 | -$1.27K | SELL | -0.35% | 80.97K | Oct 31 | ||
Aug 31, 2012 | DIRECTOR | -288.00 | $4.64 | -$1.34K | SELL | -0.37% | 76.60K | Aug 29 | ||
Dec 29, 2011 | VP, CLINICAL, REG, & QUALITY | -13.99K | $2.05 | -$28.68K | SELL | -47.47% | 15.48K | Dec 27 - Dec 29 | ||
Dec 29, 2011 | VP, GENERAL COUNSEL | -11.07K | $2.02 | -$22.42K | SELL | -90.29% | 1.19K | Dec 27 - Dec 29 | ||
Dec 29, 2011 | CFO | -4.56K | $2.12 | -$9.68K | SELL | -9.88% | 41.64K | Dec 27 - Dec 28 | ||
Dec 29, 2011 | VP, FINANCE | 5.66K | $2.08 | $11.17K | s | ∞ | 5.16K | Dec 27 - Dec 29 | ||
Dec 23, 2011 | VP, CLINICAL, REG, & QUALITY | -6.02K | $2.22 | -$13.35K | SELL | -16.96% | 29.46K | Dec 21 - Dec 23 | ||
Dec 23, 2011 | VP, GENERAL COUNSEL | -4.13K | $2.22 | -$9.17K | SELL | -25.20% | 12.27K | Dec 21 - Dec 23 | ||
Dec 23, 2011 | CFO | -5.43K | $2.22 | -$12.05K | SELL | -10.52% | 46.21K | Dec 21 - Dec 23 | ||
Dec 23, 2011 | VP FINANCE | -3.48K | $2.22 | -$7.72K | SELL | -19.38% | 14.47K | Dec 21 - Dec 23 | ||
Aug 17, 2011 | CHAIRMAN & CEO | 2.15M | $0.51 | $1.10M | BUY | 26.34% | 10.32M | Aug 16 | ||
Oct 28, 2010 | VP, CLIN, REG & QUALITY | 0.00 | $0.97 | $41.65 | GRANT | 0.00% | 144.09K | Oct 26 | ||
Oct 28, 2010 | VP AND GENERAL COUNSEL | 0.00 | $0.98 | $0.00 | GRANT | 0.00% | 56.49K | Oct 26 - Oct 27 | ||
Oct 28, 2010 | CFO | 2.25K | $0.97 | $2.23K | GRANT | 1.37% | 166.75K | Oct 26 - Oct 28 | ||
Oct 28, 2010 | VP, FINANCE | 0.00 | $0.97 | $25.00 | GRANT | 0.00% | 71.65K | Oct 26 | ||
Sep 14, 2010 | VP, CLIN, REG & QUALITY | 3.55K | $0.92 | $3.33K | GRANT | 2.52% | 144.09K | Sep 10 - Sep 14 | ||
Sep 14, 2010 | VP AND GENERAL COUNSEL | 0.00 | $0.92 | $53.66 | GRANT | 0.00% | 56.49K | Sep 10 - Sep 14 | ||
Sep 14, 2010 | CFO | 3.00K | $0.92 | $2.83K | GRANT | 1.24% | 244.10K | Sep 10 - Sep 14 | ||
Sep 14, 2010 | VP, FINANCE | 1.97K | $0.92 | $1.86K | GRANT | 2.82% | 71.65K | Sep 10 - Sep 14 | ||
Jul 28, 2010 | VP, CLIN, REG & QUALITY | 2.00 | $0.79 | -$37.99 | GRANT | 0.00% | 140.54K | Jul 26 | ||
Jul 28, 2010 | CFO | 2.23K | $0.86 | $1.55K | GRANT | 0.93% | 241.10K | Jul 26 - Jul 27 | ||
Jul 28, 2010 | VP, FINANCE | 0.00 | $0.80 | -$25.00 | GRANT | 0.00% | 69.68K | Jul 26 | ||
May 19, 2010 | DIRECTOR | 10.00K | $1.34 | $13.40K | BUY | ∞ | 10.00K | May 18 | ||
Apr 28, 2010 | VP, CLIN, REG & QUALITY | 2.00 | $1.20 | -$100.08 | GRANT | 0.00% | 140.54K | Apr 26 | ||
Apr 28, 2010 | CFO | 1.80K | $1.18 | $2.20K | GRANT | 0.76% | 238.87K | Apr 26 - Apr 27 | ||
Apr 28, 2010 | VP, FINANCE | 0.00 | $1.20 | -$58.00 | GRANT | 0.00% | 69.68K | Apr 26 | ||
Mar 18, 2010 | VP AND GENERAL COUNSEL | -29.04K | $0.76 | -$22.01K | SELL | -36.06% | 51.49K | Mar 16 | ||
Mar 11, 2010 | CHAIRMAN & CEO | 143.95K | $0.78 | $109.31K | GRANT | 1.02% | 14.25M | Mar 10 - Mar 11 | ||
Jan 21, 2010 | VP, CLIN, REG & QUALITY | 238.74K | $0.88 | $210.10K | GRANT | ∞ | 140.54K | Jan 19 - Jan 20 | ||
Jan 21, 2010 | VP AND GENERAL COUNSEL | 187.58K | $0.88 | $164.45K | GRANT | ∞ | 80.53K | Jan 19 - Jan 20 | ||
Jan 21, 2010 | CFO | 200.27K | $0.89 | $177.27K | GRANT | 544.22% | 237.07K | Jan 19 - Jan 20 | ||
Jan 21, 2010 | VP, FINANCE | 157.74K | $0.88 | $138.29K | GRANT | ∞ | 69.68K | Jan 19 - Jan 20 | ||
Sep 14, 2009 | VP AND GENERAL COUNSEL | 2.24K | $2.36 | $5.46K | GRANT | 2.86% | 80.53K | Sep 10 - Sep 11 | ||
Sep 14, 2009 | VP, FINANCE | 2.01K | $2.36 | $4.92K | GRANT | 2.97% | 69.68K | Sep 10 - Sep 11 | ||
Sep 14, 2009 | VP, CLIN, REG & QUALITY | 3.63K | $2.36 | $8.82K | GRANT | 3.53% | 106.43K | Sep 10 - Sep 11 | ||
Jul 17, 2009 | VP, CLIN., REG. & QUAL. | 81.63K | $1.68 | -$56.25K | GRANT | 385.54% | 102.80K | Jul 14 - Jul 16 | ||
Jul 17, 2009 | VP AND GENERAL COUNSEL | 43.62K | $1.67 | -$39.44K | GRANT | 125.79% | 78.29K | Jul 14 - Jul 16 | ||
Jul 17, 2009 | CFO | 69.40K | $1.66 | -$76.02K | GRANT | 77.04% | 159.50K | Jul 14 - Jul 16 | ||
Jul 17, 2009 | VP, FINANCE | 39.02K | $1.66 | -$45.73K | GRANT | 136.20% | 67.67K | Jul 14 - Jul 16 | ||
Jul 17, 2009 | CHAIRMAN & CEO | 192.30K | $1.66 | -$228.31K | GRANT | 1.39% | 14.02M | Jul 14 - Jul 16 | ||
Jun 29, 2009 | CHAIRMAN & CEO | 25.00K | $1.97 | $49.25K | BUY | 0.18% | 13.82M | Jun 25 | ||
Jun 29, 2009 | VP, CLIN., REG. AND QUAL. | 25.00K | $1.97 | $49.25K | s | ∞ | 21.17K | Jun 25 | ||
Feb 25, 2009 | DIRECTOR | 10.00K | $0.37 | $3.70K | BUY | 10.53% | 105.00K | Feb 25 | ||
Sep 05, 2008 | DIRECTOR | 10.00K | $1.71 | $17.13K | BUY | 25.00% | 50.00K | Sep 03 - Sep 04 | ||
May 20, 2008 | DIRECTOR | 15.00K | $2.36 | $35.35K | BUY | 300.00% | 20.00K | May 16 | ||
Jan 11, 2008 | CHAIRMAN AND CEO | 1.71M | $3.00 | $5.13M | BUY | 15.61% | 12.66M | Jan 09 | ||
Sep 14, 2007 | CHAIRMAN AND CEO | 50.00K | $2.33 | $116.57K | BUY | 0.43% | 11.76M | Sep 14 | ||
Mar 16, 2007 | CHAIRMAN AND CEO | 10.00K | $2.03 | $20.29K | BUY | 0.09% | 11.71M | Mar 15 | ||
Mar 14, 2007 | CHAIRMAN AND CEO | 25.00K | $2.00 | $50.09K | BUY | 0.21% | 11.70M | Mar 13 - Mar 14 | ||
Mar 14, 2007 | CFO | 10.00K | $1.96 | $19.57K | BUY | 82.79% | 22.08K | Mar 12 - Mar 13 | ||
Mar 13, 2007 | CHAIRMAN AND CEO | 25.00K | $1.91 | $47.81K | BUY | 0.21% | 11.67M | Mar 12 | ||
Mar 12, 2007 | CHAIRMAN AND CEO | 50.00K | $1.83 | $91.27K | BUY | 0.43% | 11.65M | Mar 08 - Mar 09 | ||
Feb 13, 2007 | DIRECTOR | -50.00K | $1.93 | -$96.50K | SELL | -96.88% | 1.61K | Feb 09 | ||
Feb 13, 2007 | CEO AND CHAIRMAN THE BOARD | 50.00K | $1.93 | $96.50K | BUY | 0.43% | 11.60M | Feb 09 | ||
Dec 15, 2006 | DIRECTOR | -5.00K | $1.95 | -$9.76K | SELL | -100.00% | 0.00 | Dec 14 | ||
Nov 06, 2006 | DIRECTOR | -4.50K | $2.15 | -$9.68K | SELL | -100.00% | 0.00 | Nov 02 | ||
Oct 28, 2004 | CHAIRMAN AND CEO | 25.00K | $6.39 | $159.76K | BUY | 0.22% | 11.49M | Oct 27 | ||
Oct 25, 2004 | CHAIRMAN AND CEO | 50.00K | $5.58 | $278.78K | BUY | 0.44% | 11.47M | Oct 22 - Oct 25 | ||
Oct 25, 2004 | CFO & SR. VP | 4.50K | $5.70 | $25.65K | BUY | 900.00% | 5.00K | Oct 22 | ||
Oct 21, 2004 | CHAIRMAN AND CEO | 100.00K | $4.74 | $474.30K | BUY | 0.88% | 11.41M | Oct 21 | ||
Sep 15, 2003 | DIRECTOR | 5.00K | $9.13 | $45.65K | BUY | ∞ | 5.00K | Apr 23 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.